Review Addresses Cell-Free DNA Sequencing in Pregnancy

Share this content:
Review Addresses Cell-Free DNA Sequencing in Pregnancy
Review Addresses Cell-Free DNA Sequencing in Pregnancy

MONDAY, Aug. 20, 2018 (HealthDay News) -- Cell-free DNA (cfDNA) sequencing represents an advance in genomic medicine and has associated ethical challenges, according to a review article published in the Aug. 2 issue of the New England Journal of Medicine.

Diana W. Bianchi, M.D., from the National Institutes of Health in Bethesda, Md., and Rossa W.K. Chiu, M.B.B.S., Ph.D., from the Chinese University of Hong Kong, address the implementation of cfDNA sequencing in pregnancy and associated ethical concerns.

The researchers note that the clinical adoption of cfDNA sequencing for chromosomal aneuploidy screening has already had a global effect. Professional guidelines recommend cfDNA testing for trisomy 21, 18, and 13 for pregnant women at high risk for fetal aneuploidy; some guidelines support testing for all women. The spectrum of chromosomal aberrations that are reportable by cfDNA testing has greatly expanded recently; however, this is not currently recommended for routine screening, as there are limited prospective studies and incomplete outcome data. At present, no oversight or approval for testing is provided by the U.S. Food and Drug Administration. In addition, ongoing competition among commercial groups has led to introduction of testing before demonstration of clinical utility. An education gap has been noted, as techniques were developed after providers received their training.

"Maternal plasma cfDNA sequencing represents a major advance in genomic medicine that has resulted in more precise screening, reduced invasive procedures, and created multiple ethical challenges," the authors write.

The authors disclosed financial ties to companies that offer sequencing and genetic testing technologies.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Quick New Ebola Test Approved by FDA

Quick New Ebola Test Approved by FDA

Administration authorizes emergency use of first Ebola fingerstick test with portable reader

CDC: Gun Deaths on the Rise in the United States

CDC: Gun Deaths on the Rise in the ...

U.S. has world's highest rate of gun ownership by civilians among industrialized countries

FDA to Ban Most Flavored Electronic Cigarettes

FDA to Ban Most Flavored Electronic Cigarettes

Details of the ban expected to be announced next week

is free, fast, and customized just for you!




Already a member?

Sign In Now »